Stress and cortisol in Parkinson's disease

Abel, 2013, Sleep, plasticity and memory from molecules to whole-brain networks, Current Biology, 23, R774, 10.1016/j.cub.2013.07.025 Anzak, 2011, Improvements in rate of development and magnitude of force with intense auditory stimuli in patients with Parkinson's disease, European Journal of Neuroscience, 34, 124, 10.1111/j.1460-9568.2011.07735.x Asmus, 2008, Kick and rush: Paradoxical kinesia in Parkinson disease, Neurology, 71, 695, 10.1212/01.wnl.0000324618.88710.30 Babenko, 2012, Epigenetic programming of neurodegenerative diseases by an adverse environment, Brain Research, 1444, 96, 10.1016/j.brainres.2012.01.038 Bastide, 2017, Involvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesia, Scientific Reports, 7, 10.1038/s41598-017-02572-9 Bellomo, 1991, Plasma profiles of adrenocorticotropic hormone, cortisol, growth hormone and prolactin in patients with untreated Parkinson's disease, Journal of Neurology, 238, 19, 10.1007/BF00319704 Bocharov, 2010, Therapeutic efficacy of the neuroprotective plant adaptogen in neurodegenerative disease (Parkinson's disease as an example), Bulletin of Experimental Biology and Medicine, 149, 682, 10.1007/s10517-010-1023-z Bonanni, 2010, Protracted benefit from paradoxical kinesia in typical and atypical parkinsonisms, Neurological Sciences, 31, 751, 10.1007/s10072-010-0403-5 Bonanni, 2010, Paradoxical kinesia in parkinsonian patients surviving earthquake, Movement Disorders, 25, 1302, 10.1002/mds.23075 Bostan, 2010, The basal ganglia communicate with the cerebellum, Proceedings of the National Academy of Sciences of the United States of America, 107, 8452, 10.1073/pnas.1000496107 Bouma, 2012, Genetically based reduced MAOA and COMT functioning is associated with the cortisol stress response: A replication study, Molecular Psychiatry, 17, 119, 10.1038/mp.2011.115 Breen, 2014, Sleep and circadian rhythm regulation in early Parkinson disease, JAMA Neurology, 71, 589, 10.1001/jamaneurol.2014.65 Cash, 2015, Randomized controlled expressive writing pilot in individuals with Parkinson's disease and their caregivers, BMC Psychology, 3, 44, 10.1186/s40359-015-0101-4 Clark, 2013, Psychosocial risk factors, pre-motor symptoms and first-time hospitalization with Parkinson's disease: A prospective cohort study, European Journal of Neurology, 20, 1113, 10.1111/ene.12117 Cohen, 2012, Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk, Proceedings of the National Academy of Sciences of the United States of America, 109, 5995, 10.1073/pnas.1118355109 Colpaert, 1987, Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat, Neuropharmacology, 26, 1431, 10.1016/0028-3908(87)90110-9 Daroff, 2008, Paradoxical kinesia, Movement Disorders, 23, 1193, 10.1002/mds.22060 Das, 2019, Episodic recognition memory and the hippocampus in Parkinson's disease: A review, Cortex, 113, 191, 10.1016/j.cortex.2018.11.021 De Kloet, 2005, Stress and the brain: From adaptation to disease, Nature Reviews Neuroscience, 6, 463, 10.1038/nrn1683 De La Fuente-Fernández, 2002, The placebo effect in Parkinson's disease, Trends in Neurosciences, 25, 302, 10.1016/S0166-2236(02)02181-1 De Pablo-Fernandez, 2017, Hypothalamic α-synuclein and its relation to weight loss and autonomic symptoms in Parkinson's disease, Movement Disorders, 32, 296, 10.1002/mds.26868 De Pablo-Fernandez, 2018, A histologic study of the circadian system in Parkinson disease, multiple system atrophy, and progressive supranuclear palsy, JAMA Neurology, 75, 1008, 10.1001/jamaneurol.2018.0640 De Pablos, 2014, Chronic stress enhances microglia activation and exacerbates death of nigral dopaminergic neurons under conditions of inflammation, Journal of Neuroinflammation, 11, 34, 10.1186/1742-2094-11-34 Distler, 2016, Paradoxical kinesia in Parkinson's disease revisited: Anticipation of temporal constraints is critical, Neuropsychologia, 86, 38, 10.1016/j.neuropsychologia.2016.04.012 Djamshidian, 2014, Can stress trigger Parkinson's disease?, Journal of Neurology, Neurosurgery and Psychiatry, 85, 879, 10.1136/jnnp-2013-305911 Djamshidian, 2011, Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour, Journal of Neurology, Neurosurgery and Psychiatry, 82, 1107, 10.1136/jnnp.2011.245746 Dufour, 2016, Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington's disease, Experimental Neurology, 283, 308, 10.1016/j.expneurol.2016.06.028 Elcombe, 2015, Hippocampal volume in older adults at risk of cognitive decline: The role of sleep, vascular risk, and depression, Journal of Alzheimer's Disease: JAD, 44, 1279, 10.3233/JAD-142016 Ennis, 2017, Long-term cortisol measures predict Alzheimer disease risk, Neurology, 88, 371, 10.1212/WNL.0000000000003537 Erdmann, 2008, Genetic dissection of glucocorticoid receptor function in the mouse brain, Journal of Neuroendocrinology, 20, 655, 10.1111/j.1365-2826.2008.01717.x Erkut, 1998, Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons, Journal of Clinical Endocrinology and Metabolism, 83, 2066 Fang, 2010, Depression and the subsequent risk of Parkinson's disease in the NIH-AARP diet and health study, Movement Disorders, 25, 1157, 10.1002/mds.23092 Fifel, 2014, Alteration of daily and circadian rhythms following dopamine depletion in MPTP treated non-human primates, PLoS One, 9, e86240, 10.1371/journal.pone.0086240 Glickstein, 1991, Paradoxical movement in Parkinson's disease, Trends in Neurosciences, 14, 480, 10.1016/0166-2236(91)90055-Y Gowers, 1888, Review: A manual of diseases of the nervous system, Journal of Nervous and Mental Disease, 13, 325, 10.1097/00005053-188805000-00004 Gruden, 2011, Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression, Journal of Neuroimmunology, 233, 221, 10.1016/j.jneuroim.2010.12.001 Håglin, 2016, Covariation between plasma phosphate and daytime cortisol in early Parkinson's disease, Brain and Behavior, 6, e00556, 10.1002/brb3.556 Hammond, 2010, New developments: falls, drooling & exercise in Parkinson's Disease Happe, 2004, Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease, Movement Disorders, 19, 1511, 10.1002/mds.20244 Harris, 2013, Mineralocorticoid and glucocorticoid receptor balance in control of HPA axis and behaviour, Psychoneuroendocrinology, 38, 648, 10.1016/j.psyneuen.2012.08.007 Hartmann, 1997, Twenty-four hour cortisol release profiles in patients with Alzheimer's and Parkinson's disease compared to normal controls: Ultradian secretory pulsatility and diurnal variation, Neurobiology of Aging, 18, 285, 10.1016/S0197-4580(97)80309-0 Hemmerle, 2012, Stress, depression and Parkinson's disease, Experimental Neurology, 233, 79, 10.1016/j.expneurol.2011.09.035 Hempstead, 2015, Brain-derived neurotrophic factor: Three ligands, many actions, Transactions of the American Clinical and Climatological Association, 126, 9 Herman, 2003, Central mechanisms of stress integration: Hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness, Frontiers in Neuroendocrinology, 24, 151, 10.1016/j.yfrne.2003.07.001 Hirasawa-Fujitaa, 2018, Genotypic and haplotypic associations of catechol-O-methyltransferase (COMT) rs4680 and rs4818 with salivary cortisol in patients with schizophrenia, Psychiatry Research, 259, 262, 10.1016/j.psychres.2017.10.037 Holsboer, 2000, The corticosteroid receptor hypothesis of depression, Neuropsychopharmacology, 23, 477, 10.1016/S0893-133X(00)00159-7 Hoogendijk, 1998, Depression in Parkinson's disease is not accompanied by more corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus, Biological Psychiatry, 43, 913, 10.1016/S0006-3223(97)00338-7 Ibrahimagic, 2016, Psychological stress and changes of hypothalamic-pituitary-adrenal axis in patients with “de novo” Parkinson's disease, Medical Archives (Sarajevo, Bosnia and Herzegovina), 70, 445 Jabbi, 2007, Convergent genetic modulation of the endocrine stress response involves polymorphic variations of 5-HTT, COMT and MAOA, Molecular Psychiatry, 12, 483, 10.1038/sj.mp.4001975 Joëls, 2012, Unraveling the time domains of corticosteroid hormone influences on brain activity: Rapid, slow, and chronic modes, Pharmacological Reviews, 64, 901, 10.1124/pr.112.005892 Kanherkar, 2014, Cellular reprogramming for understanding and treating human disease, Frontiers in Cell and Development Biology, 2, 67, 10.3389/fcell.2014.00067 Keefe, 1989, Paradoxical kinesia in parkinsonism is not caused by dopamine release: Studies in an animal model, Archives of Neurology, 46, 1070, 10.1001/archneur.1989.00520460046012 Kelly, 2012, Chronic exposure to corticosterone enhances the neuroinflammatory and neurotoxic responses to methamphetamine, Journal of Neurochemistry, 122, 995, 10.1111/j.1471-4159.2012.07864.x Kim, 2018, Dopamine-related dissociation of cortical and subcortical brain activations in cognitively unimpaired Parkinson's disease patients OFF and ON medications, Neuropsychologia, 119, 24, 10.1016/j.neuropsychologia.2018.07.024 Kong, 2019, Chronic unpredictable mild stress accelerates lipopolysaccharide- induced microglia activation and damage of dopaminergic neurons in rats, Pharmacology Biochemistry and Behavior, 179, 142, 10.1016/j.pbb.2019.01.004 Kordower, 2000, Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease, Science, 290, 767, 10.1126/science.290.5492.767 Kretz, 1999, Corticotropin-releasing hormone expression is the major target for glucocorticoid feedback-control at the hypothalamic level, Brain Research, 818, 488, 10.1016/S0006-8993(98)01277-3 Lederbogen, 2011, City living and urban upbringing affect neural social stress processing in humans, Nature, 474, 498, 10.1038/nature10190 Lee, 2017, Hydrocortisone-induced parkin prevents dopaminergic cell death via CREB pathway in Parkinson's disease model, Scientific Reports, 7, 525, 10.1038/s41598-018-36692-7 Leproult, 1997, Sleep loss results in an elevation of cortisol levels the next evening, Sleep, 20, 865 Li, 2018, Analysis of white matter characteristics with tract-based spatial statistics according to diffusion tensor imaging in early Parkinson's disease, Neuroscience Letters, 675, 127, 10.1016/j.neulet.2017.11.064 Liston, 2013, Circadian glucocorticoid oscillations promote learning-dependent synapse formation and maintenance, Nature Neuroscience, 16, 698, 10.1038/nn.3387 Logan, 2019, Rhythms of life: Circadian disruption and brain disorders across the lifespan, Nature Reviews Neuroscience, 20, 49, 10.1038/s41583-018-0088-y Lotharius, 2002, Effect of mutant α-synuclein on dopamine homeostasis in a new human mesencephalic cell line, Journal of Biological Chemistry, 277, 38884, 10.1074/jbc.M205518200 Lotharius, 2002, Pathogenesis of Parkinson's disease: Dopamine, vesicles and α-synuclein, Nature Reviews Neuroscience, 3, 932, 10.1038/nrn983 Lovallo, 2017, Joint impact of early life adversity and COMT Val158Met (rs4680) genotypes on the adult cortisol response to psychological stress, Psychosomatic Medicine, 79, 631, 10.1097/PSY.0000000000000481 Lucassen, 2014, Neuropathology of stress, Acta Neuropathologica, 127, 109, 10.1007/s00401-013-1223-5 Manning, 2015, Differential hippocampal shapes in posterior cortical atrophy patients: A comparison with control and typical AD subjects, Human Brain Mapping, 36, 5123, 10.1002/hbm.22999 Marshall, 1976, Activation-induced restoration of sensorimotor functions in rats with dopamine-depleting brain lesions, Journal of Comparative and Physiological Psychology, 90, 536, 10.1037/h0077230 McEwen, 2003, Mood disorders and allostatic load, Biological Psychiatry, 54, 200, 10.1016/S0006-3223(03)00177-X McEwen, 2007, Physiology and neurobiology of stress and adaptation: Central role of the brain, Physiological Reviews, 87, 873, 10.1152/physrev.00041.2006 Medina, 2013, Glucocorticoid and mineralocorticoid receptor expression in the human hippocampus in major depressive disorder, Journal of Psychiatric Research, 47, 307, 10.1016/j.jpsychires.2012.11.002 Menza, 2010, The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson's disease, Psychosomatics, 51, 474 Mizobuchi, 1993, Increase of plasma adrenocorticotrophin and cortisol in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated dogs, Brain Research, 612, 319, 10.1016/0006-8993(93)91678-L Moonen, 2017, An fMRI study into emotional processing in Parkinson's disease: Does increased medial prefrontal activation compensate for striatal dysfunction?, PLoS One, 12, 10.1371/journal.pone.0177085 Moore, 2001, Chronic cold stress reduces the spontaneous activity of ventral tegmental dopamine neurons, Neuropsychopharmacology, 24, 410, 10.1016/S0893-133X(00)00188-3 Mpofana, 2016, Exposure to early life stress results in epigenetic changes in neurotrophic factor gene expression in a parkinsonian rat model, Parkinson's Disease, 2016, 10.1155/2016/6438783 Müller, 2007, Acute levodopa intake and associated cortisol decrease in patients with Parkinson disease, Clinical Neuropharmacology, 30, 101, 10.1097/01.WNF.0000240954.72186.91 Müller, 2007, Acute levodopa administration reduces cortisol release in patients with Parkinson's disease, Journal of Neural Transmission, 114, 347, 10.1007/s00702-006-0552-0 Nathan, 2012, How China sees America, Foreign Affairs, 91, 32 Nováková, 2011, Hormonal regulators of food intake and weight gain in Parkinson's disease after subthalamic nucleus stimulation, Neuroendocrinology Letters, 32, 437 Parker, 2008, Complex I deficiency in Parkinson's disease frontal cortex, Brain Research, 1189, 215, 10.1016/j.brainres.2007.10.061 Perier, 2012, Mitochondrial biology and Parkinson's disease, Cold Spring Harbor Perspectives in Medicine, 2, 10.1101/cshperspect.a009332 Pierre, 2017, The hepato-hypothalamic-pituitary-adrenal-renal axis: Mathematical modeling of cortisol's production, metabolism, and seasonal variation, Journal of Biological Rhythms, 32, 469, 10.1177/0748730417729929 Pistollato, 2016, Associations between sleep, cortisol regulation, and diet: Possible implications for the risk of Alzheimer disease, Advances in Nutrition: An International Review Journal, 7, 679, 10.3945/an.115.011775 Plog, 2018, The glymphatic system in central nervous system health and disease: Past, present, and future, Annual Review of Pathology: Mechanisms of Disease, 13, 379, 10.1146/annurev-pathol-051217-111018 Qi, 2013, Aberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients, Psychoneuroendocrinology, 38, 863, 10.1016/j.psyneuen.2012.09.014 Qian, 2012, Circadian and ultradian rhythms of free glucocorticoid hormone are highly synchronized between the blood, the subcutaneous tissue, and the brain, Endocrinology, 153, 4346, 10.1210/en.2012-1484 Raadsheer, 1995, Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression, American Journal of Psychiatry, 152, 1372, 10.1176/ajp.152.9.1372 Ricci, 2015, Orthostatic hypotension: Epidemiology, prognosis, and treatment, Journal of the American College of Cardiology, 66, 848, 10.1016/j.jacc.2015.06.1084 Ridder, 2005, Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions, Journal of Neuroscience, 25, 6243, 10.1523/JNEUROSCI.0736-05.2005 Rod, 2013, Major life events and development of major depression in Parkinson's disease patients, European Journal of Neurology, 20, 663, 10.1111/ene.12019 Ron, 2005, Ontogeny and the effects of corticosteriod pretreatment on aquaporin water channels in the ovine cerebral cortex, Reproduction, Fertility and Development, 17, 535, 10.1071/RD03044 Rutten, 2019, Bright light therapy for depression in Parkinson disease: A randomized controlled trial, Neurology, 92, E1145, 10.1212/WNL.0000000000007090 Růžička, 2015, Chronic stress-like syndrome as a consequence of medial site subthalamic stimulation in Parkinson's disease, Psychoneuroendocrinology, 52, 302, 10.1016/j.psyneuen.2014.12.001 Sapolsky, 1996, Stress, glucocorticoids, and damage to the nervous system: The current state of confusion, Stress, 1, 1, 10.3109/10253899609001092 Schlesinger, 2007, Paradoxical kinesia at war, Movement Disorders, 22, 2394, 10.1002/mds.21739 Schwab, 1965, Effects of mood, motivation, stress and alertness on the performance in Parkinson's disease, European Neurology, 150, 345, 10.1159/000127780 Segerstrom, 2004, Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry, Psychological Bulletin, 130, 601, 10.1037/0033-2909.130.4.601 Seifried, 2013, Diurnal variation of hypothalamic function and chronic subthalamic nucleus stimulation in Parkinson's disease, Neuroendocrinology, 97, 283, 10.1159/000343808 Shiner, 2012, The effect of motivation on movement: A study of bradykinesia in Parkinson's disease, PLoS One, 7, e47138, 10.1371/journal.pone.0047138 Shirbin, 2013, The relationship between cortisol and verbal memory in the early stages of Huntington's disease, Journal of Neurology, 260, 891, 10.1007/s00415-012-6732-y Shirbin, 2013, Cortisol and depression in pre-diagnosed and early stage Huntington's disease, Psychoneuroendocrinology, 38, 2439, 10.1016/j.psyneuen.2012.10.020 Sieurin, 2018, Occupational stress and risk for Parkinson's disease: A nationwide cohort study, Movement Disorders, 33, 1456, 10.1002/mds.27439 Smith, 2008, Stress accelerates neural degeneration and exaggerates motor symptoms in a rat model of Parkinson's disease, European Journal of Neuroscience, 27, 2133, 10.1111/j.1460-9568.2008.06177.x Smyth, 2019, Endurance exercise reduces cortisol in Parkinson's disease with mild cognitive impairment, Movement Disorders, 34, 1238, 10.1002/mds.27719 Spencer, 2018, Glucocorticoid hormones are both a major circadian signal and major stress signal: How this shared signal contributes to a dynamic relationship between the circadian and stress systems, Frontiers in Neuroendocrinology, 49, 52, 10.1016/j.yfrne.2017.12.005 Stopa, 1999, Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia, Journal of Neuropathology and Experimental Neurology, 58, 29, 10.1097/00005072-199901000-00004 Stypuła, 1996, Evaluation of interleukins, acth, cortisol and prolactin concentrations in the blood of patients with Parkinson's disease, Neuroimmunomodulation, 3, 131, 10.1159/000097237 Svensson, 2016, Adjustment disorder and risk of Parkinson's disease, European Journal of Neurology, 23, 751, 10.1111/ene.12933 Swaab, 2005, The stress system in the human brain in depression and neurodegeneration, Ageing Research Reviews, 4, 141, 10.1016/j.arr.2005.03.003 van Wamelen, 2019, Slave to the rhythm: Seasonal differences in non-motor symptoms in Parkinson's disease, Parkinsonism & Related Disorders, 63, 73, 10.1016/j.parkreldis.2019.02.041 Vardi, 1976, Weight loss in patients treated long-term with levodopa. Metabolic aspects, Journal of the Neurological Sciences, 30, 33, 10.1016/0022-510X(76)90253-7 Ventura-Silva, 2012, Stress shifts the response of the bed nucleus of the stria terminalis to an anxiogenic mode, European Journal of Neuroscience, 36, 3396, 10.1111/j.1460-9568.2012.08262.x Vlajinac, 2013, The stressful life events and Parkinson's disease: A case-control study, Stress and Health, 29, 50, 10.1002/smi.2424 Vogel, 1986, Effect of hypoglycaemia, TRH and levodopa on plasma growth hormone, prolactin, thyrotropin and cortisol in Parkinson's disease before and during therapy, Journal of Neurology, 233, 149, 10.1007/BF00314421 Volpi, 1997, ACTH/cortisol involvement in the serotonergic disorder affecting the parkinsonian brain, Neuropsychobiology, 35, 73, 10.1159/000119394 Wang, 2012, Hippocampal GR expression is increased in elderly depressed females, Neuropharmacology, 62, 527, 10.1016/j.neuropharm.2011.09.014 Wang, 2014, Distribution of the glucocorticoid receptor in the human amygdala; changes in mood disorder patients, Brain Structure and Function, 219, 1615, 10.1007/s00429-013-0589-4 Webster, 2002, Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders, Molecular Psychiatry, 7, 985, 10.1038/sj.mp.4001139 Wei, 2007, Overexpressing the glucocorticoid receptor in forebrain causes an aging-like neuroendocrine phenotype and mild cognitive dysfunction, Journal of Neuroscience, 27, 8836, 10.1523/JNEUROSCI.0910-07.2007 Wilkins, 2014, Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies, Redox Biology, 2, 619, 10.1016/j.redox.2014.03.006 Wilson, 2019, Cortical thinning across Parkinson's disease stages and clinical correlates, Journal of the Neurological Sciences, 398, 31, 10.1016/j.jns.2019.01.020 Wu, 2013, The cerebellum in Parkinson's disease, Brain, 136, 696, 10.1093/brain/aws360 Wu, 2018, Circadian rest-activity rhythms predict cognitive function in early Parkinson's disease independently of sleep, Movement Disorders Clinical Practice, 5, 614, 10.1002/mdc3.12692 Yntema, 1987, Transient suppression by stress of haloperidol induced catalepsy by the activation of the adrenal medulla, Psychopharmacology, 91, 131, 10.1007/BF00690942 Zhang, 2019, Aquaporin 4 deletion exacerbates brain impairments in a mouse model of chronic sleep disruption, CNS Neuroscience & Therapeutics, 26, 228, 10.1111/cns.13194